Financial news: Technology

Latest News

Live

11:52am	Antengene Corporation Limited Receives HREC Approval In Australia For Phase I ATTRACT Study Of ATG-201 In B Cell-Related Autoimmune Diseases	CI
11:00am	Bio-Works receives US order worth SEK 2.8m	FW
09:01am	Nvidia shares set for $280 billion price swing after earnings, options show	RE
08-25	Health Care Flat on Retreat From Tech -- Health Care Roundup	DJ
08-25	Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution in Autoimmune Pulmonary Alveolar Proteinosis At the European Respiratory Society Congress 2026	CI
08-24	Ribomic Announces Completion of Clinical Trial Site Establishment for the Phase 3 Clinical Trial of Umedaptanib Pegol in Achondroplasia	CI
08-24	SpaceXAI Adopts NVIDIA Vera CPU to Accelerate Agentic AI at Massive Scale	CI
08-24	AIM Vaccine Co., Ltd. Submits Application For Marketing Registration Of Iterative Process High-Potency Human Diploid Cell Rabies Vaccine	CI
08-24	SpineGuard lands a new US patent in spinal guidance
08-24	FDA green lights Roche and Eli Lilly test in Alzheimer's disease
08-24	Aureus Greenway Holdings Inc. and Autonomous Power Corporation Begin Guardian Counter-UAS Manufacturing in the Gulf	CI
08-24	Capricor's Duchenne drug gets three-month FDA extension after new data submission	RE
08-24	Clearmind Medicine Advances MDMA-N-Acylethanolamines Patent Application For Treatment Of PTSD	CI
08-24	RTX clears a key milestone with its EPACS system for the F-35
08-24	Thomson Reuters Launches Proprietary Large Language Model Thomson	CI
08-24	Kongsberg Wants to Build Low-Cost Missiles in Europe - BN	FW
08-24	Ptc Therapeutics Announces New Sephience Data Reinforcing Broad Patient Benefits Including Sustained Metabolic Control and Diet Liberalization as Well as Consistent Favorable Safety Profile	CI
08-24	VERAXA Biotech AG and Secarna Pharmaceuticals GmbH & Co. KG Achieve Research Milestone in Antibody Oligonucleotide Conjugate Alliance	CI
08-24	Biomea Fusion Completes Enrollment In Covalent-211 Phase II Trial Of Icovamenib In Insulin-Deficient Type 2 Diabetes	CI
08-24	Roche Receives FDA Clearance For Elecsys Ptau217 Blood Test For Alzheimer?s Disease Assessment	CI
08-24	Insmed Incorporated Receives Approval for BRINSUPRI for the Treatment of Non-Cystic Fibrosis Bronchiectasis in Japan	CI
08-24	United Therapeutics Corporation Announces FDA Filing Acceptance Of New Drug Application For Ralinepag To Treat Pulmonary Arterial Hypertension	CI
08-24	Wolters Kluwer Transforms Trusted Legal Content into Structured, AI-Ready Intelligence That Powers the Next Wave of Legal AI	CI
08-24	Roche, Eli Lilly's Alzheimer's blood test gets FDA clearance	RE
08-24	Precision BioSciences, Inc. Commences Dosing In Phase 1/2 Function-Dmd Study	CI
08-24	Parsons Corporation Secures $514 Million Missile Defense Agency Contract Option	CI
08-24	Anbogen Therapeutics Enters Collaborative Research Agreement With The University Of Tokyo To Evaluate ABT-301 Across Multiple Tumor Types	CI
08-24	Rznomics Joins Lilly Gateway Labs In San Diego	CI
08-24	India plans first tokenised bond issue in September, sources say	RE
08-24	Gsk plc Announces Approval of Hibsago (Bepirovirsen) in Japan as First Functional Cure for Chronic Hepatitis B	CI
08-24	Gc Biopharma Receives Drug Approval for Hunterase Iv in India and Hunterase Iv and Icv in Taiwan	CI
08-24	Hungarian Gripen jet crashes, Saab slips on the stock market	FW
08-24	Hungarian Gripen jet crashes, no injuries reported, PM Magyar says	RE
08-24	Hanmi Pharmaceutical Shares Jump After Signing $2.31 Billion Licensing Deal With Genentech	DJ
08-24	Saab Unveils Its Concept for a Future Uncrewed Fighter Aircraft
08-24	Isofol Medical expands Phase Ib/II study with additional trial sites	FW
08-24	Saab Unveils Uncrewed Combat Aircraft, Could Cost Half as Much as Gripen E	FW
08-24	China evacuates tens of thousands as rain from Typhoon Narra lashes southwest	RE
08-24	Ukrainian drone attack kills three teenagers in Russia's Krasnodar, officials say	RE
08-23	Putin wants to draft 300,000 new troops, Zelenskiy says	RE
08-22	Kryvyi Rih survivor recalls casualties in parking lot after Russian strike	RE
08-22	France agrees to accelerate air defence deliveries to Ukraine, Zelenskiy says	RE
08-22	Saab Showcases Full-Scale Concept Model Of Future Uncrewed Combat Air System	CI
08-21	Genetic Analysis Launches GA-map Dysbiosis Test At Centre for Digestive Diseases in Sydney	CI
08-21	Reconart, Inc. Integrates with Solana to Support Stablecoin Remittance and Agentic Payments Reconciliation	CI
08-21	AI boom is still in 'batting practice,' CIO says	RE
08-21	D&D Pharmatech Receives Final Clinical Study Report For Phase 2 Clinical Trial Of Zabopegdutide For MASH Treatment	CI
08-21	Six killed, around 90 wounded in Russian strike on shopping centre in Ukraine	RE
08-21	Quantum X Labs Inc. Demonstrates Improved Performance of Ai-Driven Quantum Error Correction Decoder Using Google?S Dataset	CI
08-21	Akeso Receives Clinical Trial Clearance For AK157D1 B7-H3 Antibody-Drug Conjugate In Solid Tumors	CI

No results match your criteria

Most Mentioned (24h)

SAAB AB	-0.23%
NVIDIA CORPORATION	-2.91%
WOLTERS KLUWER N.V.	-1.37%
ROCHE HOLDING AG	+0.12%
SPINEGUARD	+7.83%
KONGSBERG GRUPPEN ASA	+1.46%
GSK PLC	-0.75%
RTX CORPORATION	-0.33%
INSMED INCORPORATED	-1.42%
PARSONS CORPORATION	-0.49%

Headlines

	Finnair suspends Dubai flights for the winter season 2026-2027
	MIDEAST STOCKS-Gulf stock markets muted as investors assess fresh US measures on Iran
	Nvidia shares set for $280 billion price swing after earnings, options show
	Exxon, Apollo interested in Shell's US chemical assets sale
	China robot maker Unitree's post-listing slump sparks bubble fears
	Boeing, Northrop, RTX to Provide Military Aircraft to Qatar in Proposed Sale, US State Department Says
	Saudi Aramco Reportedly Books Crude Orders from Two Chinese Buyers
	Australia's earnings season winners emerge
	Hyundai Motor, Labor Union Agree on Tentative Wage Deal
	Equinor Begins Supplying Gas to Troll A Platform From Phase 3 Project

The best tools reserved for subscribers to boost the performance of your investments!